News

May 29 2020
Coronavirus and multiple sclerosis - update

Coronavirus and multiple sclerosis - update

The Belgian Charcot Foundation adheres to the guidelines of our health authorities, which are updated when necessary.
April 29 2020
Respect

Respect

Today's heroes are not only the care workers, but also the men and women in the shadows in logistics, the post office, garbage collectors, etc., not forgetting the researchers. Their mission is to find ways to solve this crisis, today but also tomorrow.
April 27 2020
Coronavirus and multiple sclerosis

Coronavirus and multiple sclerosis

The Charcot Foundation refers to the general information on the website of the Belgian health authorities. The Charcot Foundation agrees with the opinion of the Belgian Multiple Sclerosis Study Group concerning the current coronavirus problem, namely:
January 24 2020
Innovation Made in Belgium

Innovation Made in Belgium

With 500,000 euros, the Fondation Charcot Stichting provides the essential resources for 10 teams of experienced researchers in neurology, neuroimmunology, neurobiology and rehabilitation sciences to ensure innovative and concrete advances in multiple sclerosis research.
January 2, 2020
Anne Vandamme, suffering from multiple sclerosis: I am living in the moment, with the abilities that I still have!

Anne Vandamme, suffering from multiple sclerosis: I am living in the moment, with the abilities that I still have!

Multiple sclerosis (MS) affects 12,000 people in our country. Anne Vandamme is one of them. An inspiring conversation with a patient for whom the glass is always half full, never half empty.
December 23 2019
Cannabis and MS

Cannabis and MS

Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects over two million people worldwide. Patients may suffer from a wide range of disabling complaints which are not always easy to treat. Although cannabis is best known as a psychoactive recreational drug, it is also increasingly associated with a variety of positive medical effects.
November 4 2019
Young adults and MS

Young adults and MS

Multiple sclerosis is the commonest neurological disease affecting young adults. In patients under 30, treatment needs to be adjusted accordingly.
October 15, 2019
An action for the benefit of research

An action for the benefit of research

There are many ways to support research: at a wedding, a birthday, a neighbor's day, a BBQ, by being sponsored during a run or a walk.
September 1, 2019
Patients and sport

Patients and sport

Ideally, physical activity should be started as soon as the disease is diagnosed and continued uninterrupted.
August 29, 2019
May 30: World MS Day

May 30: World MS Day

It is currently difficult for a patient to accept that their form of multiple sclerosis does not yet have a satisfactory curative response. However, current MS research offers real prospects for the future. Proof of this are the numerous treatments that were not available twenty years ago.
July 10, 2019
The Sun, Vitamin D, and MS

The Sun, Vitamin D, and MS

Vitamin D insufficiency or deficiency is common in the regions of northern Europe, since 90% of this vitamin D is formed in the skin under the effect of the sun's ultraviolet rays.
June 24 2019
An action for the benefit of research

An action for the benefit of research

There are many ways to support research: at a wedding, a birthday, a neighbor's day, a BBQ, by being sponsored during a run or a walk. It's up to you to play: our “Action” platform awaits you here.

Stay informed

Receive all the information related to research and news from the Belgian Charcot Foundation directly in your inbox.

By clicking on “I register”, you agree to our Privacy policy